At Cortex, we are developing a technologically advanced mapping and ablation solution for Atrial Fibrillation (Afib), the most common heart rhythm disorder, with determined passion. We aim to enable more precise, personalized therapy planning and delivery to optimize clinical outcomes and safety for Afib patients while simplifying workflows and improving procedural efficiency. Our technology suite will include diagnostic and pulsed field ablation catheters and a comprehensive mapping and navigation solution powered by Ablacon’s innovative Electrographic Flow® (EGF) mapping technology.